PHARMACOGENOMICS: TAILORING DRUG THERAPY BASED ON GENETIC INFORMATION
DOI:
https://doi.org/10.71465/mrcis115Keywords:
Pharmacogenomics, Personalized Medicine, Genetic Information, Adverse Drug ReactionsAbstract
Pharmacogenomics, the study of how genes affect a person’s response to drugs, is an emerging field in personalized medicine that aims to tailor drug therapies based on genetic information. This field holds the potential to improve drug efficacy, minimize adverse drug reactions (ADRs), and reduce healthcare costs. By understanding an individual’s genetic makeup, pharmacogenomics can help predict how patients will respond to specific medications, leading to more effective and safer treatments. This article explores the principles of pharmacogenomics, its clinical applications, the role of genetic variants in drug metabolism, and the challenges faced in implementing pharmacogenomics in routine clinical practice. Special focus is given to the pharmacogenomic landscape in Pakistan and its future potential in improving healthcare outcomes. The article concludes with a discussion on the ethical, social, and logistical challenges of incorporating pharmacogenomics into healthcare systems worldwidey.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Muhammad Akram, Reema Fayez Tayyem (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles published in the Multidisciplinary Research in Computing Information Systems are licensed under an open-access model. Authors retain full copyright and grant the journal the right of first publication. The content can be freely accessed, distributed, and reused for non-commercial purposes, provided proper citation is given to the original work.
